4004 ESC Guidelines label use of medication should be limited to situations where it is in
the patient's interest to do so, with regard to the quality, safety, and efficacy of care, and only …

The recommendations listed in this clinical practice guideline are, whenever possible,
evidence-based. An initial extensive evidence review, which included literature derived from …

Pacemaker treatment for bradyarrhythmia was first approved for national health insurance
coverage in Japan in 1974, and its use rapidly became widespread thereafter …

Pierwsze wytyczne ESC dotyczące postępowania w omdleniach opublikowano w 2001
roku, a ich kolejne wersje w latach 2004 i 2009. W marcu 2015 roku CPG uznała, że …

The J-wave syndromes (JWSs), consisting of the Brugada syndrome (BrS) and early
repolarization syndrome (ERS), have captured the interest of the cardiology community over …

Brugada syndrome (BrS) is an “inherited” condition characterized by predisposition to
syncope and cardiac arrest, predominantly during sleep. The prevalence is∼ 1: 2,000, and …

Abstract Aims Risk stratification in Brugada Syndrome (BS) remains challenging. Arrhythmic
events can occur life-long and studies with long follow-ups are sparse. The aim of our study …

Ventricular electrical storm (VES) is a clinical scenario characterized by the clustering of
multiple episodes of sustained ventricular arrhythmias (VA) over a short duration. Patients …

Background: Although large randomized clinical trials have found that primary prevention
use of an implantable cardioverter-defibrillator (ICD) improves survival in patients with …

Brugada syndrome (BS) is an inherited disease characterized by a coved-type ST-segment
elevation in the right precordial leads and increased risk of sudden cardiac death (SCD), in …